Jaksa A, Gibbs L, Kent S, Rowark S, et al. Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study. BMJ Open 2022;12:e064662.
PMID: 36253039